Finn L et al. |
Epstein-Barr virus infections in children after transplantation of the small intestine. |
1998 |
Am. J. Surg. Pathol. |
pmid:9500771
|
Randhawa PS et al. |
The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. |
1993 |
Am. J. Surg. Pathol. |
pmid:7680544
|
Minervini MI et al. |
Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB). |
2000 |
Am. J. Surg. Pathol. |
pmid:10757402
|
Randhawa PS et al. |
Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy. |
1996 |
Am. J. Surg. Pathol. |
pmid:8772784
|
Campbell PM et al. |
Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. |
2007 |
Am. J. Transplant. |
pmid:17456201
|
Boudjema K et al. |
Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study. |
2011 |
Am. J. Transplant. |
pmid:21466650
|
Knechtle SJ |
Guidance for liver transplant immunosuppression. |
2011 |
Am. J. Transplant. |
pmid:21466652
|
Gupta G et al. |
Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction. |
2015 |
Am. J. Transplant. |
pmid:25988397
|
Silva HT et al. |
Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:24266969
|
Ricciardelli I et al. |
Rapid generation of EBV-specific cytotoxic T lymphocytes resistant to calcineurin inhibitors for adoptive immunotherapy. |
2013 |
Am. J. Transplant. |
pmid:24266973
|
Suszynski TM et al. |
Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. |
2013 |
Am. J. Transplant. |
pmid:23432755
|
Damon C et al. |
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening. |
2017 |
Am. J. Transplant. |
pmid:27597269
|
Ferguson R et al. |
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21114656
|
McKenna G and Trotter JF |
Does early (CNI) conversion lead to eternal (renal) salvation? |
2010 |
Am. J. Transplant. |
pmid:20928938
|
Shuker N et al. |
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation. |
2016 |
Am. J. Transplant. |
pmid:26714287
|
Forns X and Navasa M |
Cyclosporine A or tacrolimus for hepatitis C recurrence? An old debate. |
2011 |
Am. J. Transplant. |
pmid:21797970
|
Arnold R et al. |
Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients. |
2013 |
Am. J. Transplant. |
pmid:23841745
|
Hirsch HH et al. |
BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12. |
2016 |
Am. J. Transplant. |
pmid:26639422
|
Bohl DL et al. |
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. |
2005 |
Am. J. Transplant. |
pmid:16095500
|
Kasahara M et al. |
Living-donor liver transplantation for hepatoblastoma. |
2005 |
Am. J. Transplant. |
pmid:16095502
|
Madeleine MM et al. |
HPV-related cancers after solid organ transplantation in the United States. |
2013 |
Am. J. Transplant. |
pmid:24119294
|
Lemahieu WP et al. |
CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus. |
2004 |
Am. J. Transplant. |
pmid:15307840
|
Bressollette-Bodin C et al. |
A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996241
|
Augustine JJ et al. |
Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients. |
2005 |
Am. J. Transplant. |
pmid:15996247
|
Filler G et al. |
Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure. |
2005 |
Am. J. Transplant. |
pmid:15996252
|
Froud T et al. |
Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. |
2005 |
Am. J. Transplant. |
pmid:15996257
|
Chodoff L and Hamberg KJ |
Response to 'Different preparations of tacrolimus and medication errors'. |
2009 |
Am. J. Transplant. |
pmid:19392982
|
Luther P and Baldwin D |
Pioglitazone in the management of diabetes mellitus after transplantation. |
2004 |
Am. J. Transplant. |
pmid:15575920
|
Cherukuri A et al. |
An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation. |
2012 |
Am. J. Transplant. |
pmid:22390816
|
Dahm F et al. |
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. |
2004 |
Am. J. Transplant. |
pmid:15575921
|
Pascher A et al. |
Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial. |
2015 |
Am. J. Transplant. |
pmid:25677074
|
Barth RN et al. |
Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. |
2011 |
Am. J. Transplant. |
pmid:21668624
|
Guirado L et al. |
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. |
2011 |
Am. J. Transplant. |
pmid:21668633
|
Flechner SM et al. |
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. |
2011 |
Am. J. Transplant. |
pmid:21668635
|
Grenda R et al. |
A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study. |
2010 |
Am. J. Transplant. |
pmid:20420639
|
Montgomery SP et al. |
Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model. |
2002 |
Am. J. Transplant. |
pmid:12118862
|
van Hooff JP et al. |
Glucose metabolic disorder after transplantation. |
2007 |
Am. J. Transplant. |
pmid:17511670
|
Silva HT et al. |
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17217442
|
Heffron TG et al. |
Once-daily tacrolimus extended-release formulation: 1-year post-conversion in stable pediatric liver transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17511684
|
Moench C et al. |
Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial. |
2007 |
Am. J. Transplant. |
pmid:17511685
|
Patlolla V et al. |
Efficacy of anti-IL-2 receptor antibodies compared to no induction and to antilymphocyte antibodies in renal transplantation. |
2007 |
Am. J. Transplant. |
pmid:17564638
|
Nijhoff MF et al. |
Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression. |
2016 |
Am. J. Transplant. |
pmid:26288226
|
Toso C et al. |
Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol. |
2006 |
Am. J. Transplant. |
pmid:16611343
|
Lacaille F et al. |
Severe dysimmune cytopenia in children treated with tacrolimus after organ transplantation. |
2006 |
Am. J. Transplant. |
pmid:16611346
|
Chamie K et al. |
The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer. |
2008 |
Am. J. Transplant. |
pmid:18853950
|
Lefaucheur C et al. |
Renal histopathological lesions after lung transplantation in patients with cystic fibrosis. |
2008 |
Am. J. Transplant. |
pmid:18671673
|
Pech T et al. |
Intestinal regeneration, residual function and immunological priming following rescue therapy after rat small bowel transplantation. |
2012 |
Am. J. Transplant. |
pmid:22974463
|
McDonald RA et al. |
Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. |
2008 |
Am. J. Transplant. |
pmid:18416737
|
Brennan DC et al. |
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. |
2005 |
Am. J. Transplant. |
pmid:15707414
|
Chhabra D et al. |
Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen. |
2013 |
Am. J. Transplant. |
pmid:24007570
|